Program Overview
Columbia University Medical Center invites you to join the leading educators from Columbia University, addressing an overview of high-yield challenging scenarios in managing C3G and Immune Complex MPGN disease. The half-day conference course is designed to enhance the knowledge of healthcare professionals on pathogenesis, genetics, pathology, and genetic variants associated with C3G disease. Through lectures and case-based presentations, this course will deliver up-to-date and cutting-edge information that can be directly integrated into clinical practice. The course is tailored for healthcare providers specializing in Nephrology and addressing these issues and includes talks, Q&A, and panel discussions.
Learning Objectives
Describe the distinct mechanisms underlying C3G and IC-MPGN, focusing on how complement dysregulation and immune complex deposition lead to these diseases.
Identify genetic and acquired disruptions in complement regulation and their impact on glomerular function in C3G and IC-MPGN
Discuss recent therapeutic advances targeting complement dysregulation, like iptacopan and pegcetacoplan, and their potential in modifying disease progression.
Differentiate primary IC-MPGN from secondary forms associated with systemic diseases, and identify diagnostic criteria for distinguishing these subtypes
Recognize the specific biopsy findings, complement assays, and genetic tests that aid in diagnosing C3G and IC GN.
Discuss the prevalence, risk factors, and demographic characteristics associated with C3G and IC-MPGN.
